View in EDS HTML Full Text PDF Full Text

Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.

Saved in:
Bibliographic Details
Title: Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.
Authors: Karaca, Irmak1 (AUTHOR), Tran, Elaine M.1 (AUTHOR), Park, SungWho1 (AUTHOR), Bromeo, Albert1 (AUTHOR), Khojasteh, Hassan1 (AUTHOR), Tran, Anh Ngọc Tram1 (AUTHOR), Yavari, Negin1 (AUTHOR), Akhavanrezayat, Amir1 (AUTHOR), Yasar, Cigdem1 (AUTHOR), Uludag Kirimli, Gunay1 (AUTHOR), Than, Ngoc Tuong Trong1 (AUTHOR), Hassan, Muhammad1 (AUTHOR), Or, Christopher1 (AUTHOR), Ghoraba, Hashem1 (AUTHOR), Do, Diana V.1 (AUTHOR), Nguyen, Quan Dong1 (AUTHOR) ndquan@stanford.edu
Source: Journal of Ophthalmic Inflammation & Infection. 3/11/2024, Vol. 14 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18695760
DOI:10.1186/s12348-023-00372-z